MITSUBISHI PHARMA TO LICENSE ZIONE INTERNAL HEMORRHOID DRUG TO YUHAN
Mitsubishi Pharma and Lequio Pharma jointly announced on February 23 that they have signed a licensing agreement with Korean pharmaceutical company Yuhan Corporation. Under the terms of the agreement, Yuhan receives the exclusive right to import and market ZIONE Injection in Korea. Yuhan aims to launch the agent as soon as possible.
JCN Network (http://www.japancorp.net/Article.Asp?Art_ID=11980)